AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
AbbVie (NYSE:ABBV) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE:ABBV) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. Company management will join a fireside chat at 9:40 a.m. Central time.
A live audio webcast and later archived replay will be available on AbbVie's investor relations website.
Details
News Market Reaction – ABBV
On Jun 2, the day this news came out, ABBV closed 1.16% above the previous close.
Data tracked by StockTitan Argus for the Jun 2 session.
Key Figures
- Conference edition
- 47th
- Goldman Sachs Annual Global Healthcare Conference
- Conference date
- June 9, 2026
- Scheduled presentation date
- Presentation time
- 9:40 a.m. Central
- Fireside chat start time
Historical Context
-
European Commission authorized expanded VENCLYXTO label for first-line CLL combinations.
-
U.S. FDA approved DECNUPAZ for adult BPDCN based on CADENZA trial data.
-
Positive CHMP opinion for MAVIRET in acute hepatitis C in adults and children.
-
ASCO 2026 presentations on next‑generation oncology pipeline across solid and blood cancers.
-
Positive CHMP opinion for Boey to treat moderate to severe glabellar lines in adults.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Marianne Ostrogorski | Investors: Liz Shea |
View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302787501.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.